When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - VistaGen +19% premarket on positive AV-101 results
VistaGen Therapeutics Inc.
VistaGen Therapeutics (NASDAQ:VTGN) is up 19% premarket on announcing successful results from a first-step, Phase 1b clinical study with healthy U.S. military Veterans, which measured NMDAR (N-methyl-D-aspartate receptor) target engagement of VistaGen's AV-101, for potential treatment of suicidal ideation in Veterans.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news, Stocks on the move,